From the Guidelines
Toradol (ketorolac) can be effective for some people with sciatica pain, but it's not typically a first-line treatment. Toradol is a potent non-steroidal anti-inflammatory drug (NSAID) that works by reducing inflammation and blocking pain signals, which can help address the inflammatory component of sciatica. The typical dose is 10mg orally every 4-6 hours as needed for pain, not to exceed 40mg daily, and it should only be used short-term (5 days or less) due to risks of serious side effects. For sciatica specifically, other treatments are often tried first, including milder NSAIDs like ibuprofen or naproxen, physical therapy, and in some cases muscle relaxants or nerve pain medications like gabapentin.
According to the American College of Physicians and the American Pain Society guidelines 1, there is little evidence to guide specific recommendations for medications (other than gabapentin) for patients with sciatica or spinal stenosis. However, nonpharmacologic therapies with proven benefits, such as spinal manipulation, intensive interdisciplinary rehabilitation, exercise therapy, acupuncture, massage therapy, yoga, cognitive-behavioral therapy, or progressive relaxation, should be considered for patients who do not improve with self-care options.
Toradol carries significant risks including stomach bleeding, kidney problems, and cardiovascular issues, especially in older adults or those with certain medical conditions. It should only be used under close medical supervision, and patients should report any unusual symptoms like stomach pain, black stools, or difficulty urinating immediately. For long-term sciatica management, addressing the underlying cause through physical therapy, proper body mechanics, and possibly other interventions is generally more appropriate than relying on Toradol.
Some key points to consider when using Toradol for sciatica pain include:
- Use the lowest effective dose for the shortest duration possible
- Monitor for signs of stomach bleeding, kidney problems, and cardiovascular issues
- Consider alternative treatments, such as physical therapy and nonpharmacologic therapies, before using Toradol
- Use Toradol under close medical supervision, especially in older adults or those with certain medical conditions.
From the Research
Effectiveness of Toradol with Sciatica
- The provided studies do not directly investigate the effectiveness of Toradol (ketorolac) with sciatica. However, they do discuss the use of epidural steroid injections and other treatments for sciatica.
- A study from 2020 2 found that epidural corticosteroid injections were probably more effective than placebo in reducing short-term leg pain and disability in patients with sciatica.
- Another study from 2021 3 found that epidural steroid injections were superior to epidural placebo in reducing leg pain and improving functional status at 6 weeks and 3 months.
- A 2024 study 4 found that epidural steroid injections were effective in providing short- and medium-term pain relief for sciatica caused by lumbar disc herniation.
- A 2021 systematic review and meta-analysis 5 found that epidural injections with or without steroids showed significant effectiveness in managing lumbar radiculopathy or sciatica.
Safety Considerations
- A 2014 case report 6 highlighted the potential risk of spinal epidural hematoma following a cervical interlaminar epidural steroid injection, particularly when combined with medications like ketorolac and fluoxetine that can impair hemostasis.
- The study suggests that withholding NSAIDs, fluoxetine, fish oil, and vitamin E in the peri-procedural period may be considered for patients with multiple risk factors for spinal epidural hematoma.
Toradol and Sciatica
- While there is no direct evidence on the effectiveness of Toradol with sciatica, the medication is an NSAID that can be used to relieve pain and inflammation.
- However, its use should be carefully considered in patients with sciatica, particularly those undergoing epidural steroid injections or other procedures that may increase the risk of bleeding complications 6.